The move from the Small Cap segment is a result of Nasdaq’s annual review of the average market values within the Nordic market segments. The Mid Cap segment includes companies with a share value between
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.229 SEK | +10.10% | -36.95% | -97.70% |
Apr. 22 | Transcript : Xbrane Biopharma AB - Special Call | |
Mar. 18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
The move from the Small Cap segment is a result of Nasdaq’s annual review of the average market values within the Nordic market segments. The Mid Cap segment includes companies with a share value between
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-97.70% | 29.21M | |
+4.09% | 43.84B | |
+46.23% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |